# Medico-economic Evaluation of the Therapeutic Drug Monitoring of Anti-TNF-α Agents in Inflammatory Bowel Diseases

> **NCT02508012** · NA · COMPLETED · sponsor: **University Hospital, Montpellier** · enrollment: 260 (actual)

## Conditions studied

- Crohn's Disease
- Ulcerative Colitis

## Interventions

- **OTHER:** Immuno monitoring

## Key facts

- **NCT ID:** NCT02508012
- **Lead sponsor:** University Hospital, Montpellier
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2015-09-24
- **Primary completion:** 2020-01-01
- **Final completion:** 2020-01-01
- **Target enrollment:** 260 (ACTUAL)
- **Last updated:** 2025-09-30

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02508012

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02508012, "Medico-economic Evaluation of the Therapeutic Drug Monitoring of Anti-TNF-α Agents in Inflammatory Bowel Diseases". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT02508012. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*